Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CVS and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CVS and 80,000+ other tickers.
See exactly how CVS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CVS and 80,000+ other tickers.
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The…
CVS Health has significantly improved its business since last year. The company is performing well financially as a result.
On Aug. 31, 2026, Richard Pzena (Trades, Portfolio)'s firm, Pzena Investment Management, significantly increased its stake in Globant SA (GLOB, Financial), acqu
Continuum Advisory LLC lessened its holdings in shares of CVS Health Corporation (NYSE: CVS) by 98.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 991 shares of the pharmacy operator's stock after selling 79,745 shares during the
CVS Health is advancing Aetna's profitability turnaround, supported by stronger Health Care Benefits results, an improved MBR and operational initiatives.
Compass Financial Management LLC purchased a new stake in shares of CVS Health Corporation (NYSE: CVS) during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 5,476 shares of the pharmacy operator's stock, valued at approximately $568,000. Several other large investors also recently modified